United States Value-Based Care for Medical Technology

0

Dublin, Jan. 13, 2022 (GLOBE NEWSWIRE) — The US Value-based Care for Medical Technology Growth Opportunities report has been added to from ResearchAndMarkets.com offer.

The study will explore the underlying need and demand for VBC for the US market.

The Value-Based Model of Care (VBC) aims to deliver better outcomes and quality of care to patients in a cost-effective manner. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive to provide better value. The United States is a pioneer in the adoption of VBC, followed by Western European countries.

The geographic scope of the study will be primarily the United States. The research study will provide insight into value-based healthcare in the United States from the perspective of the medical technology industry. New models of care outside of hospital settings will effectively use limited hospital resources to meet the clinical demands of aging and chronic populations.

Effective delivery of VBC requires collaboration among stakeholders such as payers, vendors, and medical device manufacturers. Advanced technologies will cover many more acute conditions within the hospital-at-home care model and improve patient experiences and outcomes.

Main topics covered

1. Strategic imperatives

  • Why is it increasingly difficult to grow taller?
  • The strategic imperative
  • The Impact of the Top Three Strategic Imperatives on the Value Based Care (VBC) Industry in the United States (US) for Medical Technology (Medtech)
  • Growth opportunities fuel the growth pipeline engine

2. Analysis of growth opportunities

  • Scope of analysis
  • Answers to the key questions of this study
  • Defining value in the future
  • Respect the VBC framework
  • VBC will transform the structure of the system, the delivery of payments and the delivery of care in the industry
  • Growth engines
  • Growth constraints

3. Challenges and enablers of transition to value-based care

  • What keeps hospital chief executives (CEOs) awake at night
  • Future U.S. Healthcare Spending Is Unsustainable
  • Healthcare in the United States is expensive but lags behind in delivering value
  • Statistical Alert 1-Strong need for optimal use of healthcare resources
  • Statistical Alert 2 – Need to improve population health and clinical outcomes
  • Is saved waste value earned?
  • Challenges in adopting new technologies
  • Impact of COVID-19 on hospital margins in 2021
  • Strategic imperatives guiding ambulatory care

4. Assessment of ACV potential by medical specialty

  • Evaluation of BCV potential by medical specialty
  • Cardiology
  • Orthopedics
  • Oncology
  • Gastroenterology
  • Neurology
  • Nephrology
  • Pulmonology
  • Endocrinology

5. Achieve value in care delivery

  • VBC to help transform care delivery
  • Strong underlying fundamentals support changes in care delivery
  • Changes in care delivery to impact patient volume dynamics
  • Impact analysis on the volume of hospitalized patients
  • Impact analysis on the volume of outpatients
  • 1-value trend factors to drive constant AUC growth
  • Trend 2 – Growth of Responsible Care Organizations (ACOs) towards the plateau, but the future of value-based care must remain intact
  • 3-Payer Support Trend to Drive HaH Adoption
  • Trend 4 – Hospitals focus on post-discharge/transition clinics to reduce readmission rates
  • Trend 5-Telemedicine in rural hospitals
  • Trend 6-Virtualization of primary care
  • Trend 7 – The inclination towards on-demand care will lead to an increase in urgent care clinics
  • 8-COVID-19 Trend to Accelerate Retail Clinic Utilization
  • Trend 9-2019 Emergency and Retail Clinic Utilization Trends
  • Strategic Implications and Call to Action for Medtech Stakeholders

6. Regulatory reforms and policies to enable new models of care

  • Support regulatory and reimbursement policies
  • Future Direction – Transition to APM and Population Health Plans
  • Strategic Implications and Call to Action for Medtech Stakeholders

7. Technological innovation in care

  • Population health management (PHM), at the heart of value-based reimbursement, is a difficult undertaking for providers
  • AI and the Internet of Medical Things (IoMT) – 2 major technology enablers for value-based care
  • The right care at the right time via the right means – A connected IoMT
  • IoMT Enables Transition of Care Delivery
  • Digitized Data Boom – A push towards predictive care to drive demand for AI solutions for healthcare
  • AI to improve workflow efficiency and care delivery
  • Patient Data Stratification and Sources for Precision Health and PHM
  • Combinatorial Care Delivery Technologies to Generate Value
  • Support technologies so that the continuum of care is generalized
  • Adopting technology to enable patient-centric solutions
  • Strategic Implications and Call to Action for Medtech Stakeholders

8. Funding and Payment Models

  • Medical technology players will need to consider changing financial risks
  • VBC payments stats point to vendor-dividing adoption
  • Need to optimize the approach to analyzing the value of purchases
  • Current adoption of VBC payment contracts in Medtech
  • Strategic Implications and Call to Action for Medtech Stakeholders

9. Universe of growth opportunities

  • Growth Opportunity 1: Develop effective interoperability solutions to fill data gaps
  • Growth Opportunity 2: Designing a Comprehensive Strategic Framework for Competitive Advantage
  • Growth Opportunity 3: Target Emerging Markets for Market Expansion Options

10. Next steps

For more information about this report visit https://www.researchandmarkets.com/r/kn43rq


        


Source link

Share.

Comments are closed.